Screening for colorectal cancer: what fits best?

Hdl Handle:
http://hdl.handle.net/10147/264504
Title:
Screening for colorectal cancer: what fits best?
Authors:
Lee, Chun Seng; Ronan, Leen; O'Morain, Colm; McNamara, Deirdre
Affiliation:
Department of Clinical Medicine, Trinity Centre for Health Sciences, Adelaide and Meath Hospital, Dublin, Ireland. leecs@tcd.ie
Citation:
Screening for colorectal cancer: what fits best? 2012, 6 (3):301-12 Expert Rev Gastroenterol Hepatol
Journal:
Expert review of gastroenterology & hepatology
Issue Date:
Jun-2012
URI:
http://hdl.handle.net/10147/264504
DOI:
10.1586/egh.12.12
PubMed ID:
22646253
Abstract:
Colorectal cancer (CRC) screening has been shown to be effective in reducing CRC incidence and mortality. There are currently a number of screening modalities available for implementation into a population-based CRC screening program. Each screening method offers different strengths but also possesses its own limitations as a population-based screening strategy. We review the current evidence base for accepted CRC screening tools and evaluate their merits alongside their challenges in fulfilling their role in the detection of CRC. We also aim to provide an outlook on the demands of a low-risk population-based CRC screening program with a view to providing insight as to which modality would best suit current and future needs.
Item Type:
Article
Language:
en
MeSH:
Colonoscopy; Colorectal Neoplasms; Cost-Benefit Analysis; Humans; Immunologic Tests; Mass Screening; Occult Blood; Sigmoidoscopy
ISSN:
1747-4132

Full metadata record

DC FieldValue Language
dc.contributor.authorLee, Chun Sengen_GB
dc.contributor.authorRonan, Leenen_GB
dc.contributor.authorO'Morain, Colmen_GB
dc.contributor.authorMcNamara, Deirdreen_GB
dc.date.accessioned2013-01-08T15:52:12Z-
dc.date.available2013-01-08T15:52:12Z-
dc.date.issued2012-06-
dc.identifier.citationScreening for colorectal cancer: what fits best? 2012, 6 (3):301-12 Expert Rev Gastroenterol Hepatolen_GB
dc.identifier.issn1747-4132-
dc.identifier.pmid22646253-
dc.identifier.doi10.1586/egh.12.12-
dc.identifier.urihttp://hdl.handle.net/10147/264504-
dc.description.abstractColorectal cancer (CRC) screening has been shown to be effective in reducing CRC incidence and mortality. There are currently a number of screening modalities available for implementation into a population-based CRC screening program. Each screening method offers different strengths but also possesses its own limitations as a population-based screening strategy. We review the current evidence base for accepted CRC screening tools and evaluate their merits alongside their challenges in fulfilling their role in the detection of CRC. We also aim to provide an outlook on the demands of a low-risk population-based CRC screening program with a view to providing insight as to which modality would best suit current and future needs.en_GB
dc.language.isoenen
dc.rightsArchived with thanks to Expert review of gastroenterology & hepatologyen_GB
dc.subject.meshColonoscopy-
dc.subject.meshColorectal Neoplasms-
dc.subject.meshCost-Benefit Analysis-
dc.subject.meshHumans-
dc.subject.meshImmunologic Tests-
dc.subject.meshMass Screening-
dc.subject.meshOccult Blood-
dc.subject.meshSigmoidoscopy-
dc.titleScreening for colorectal cancer: what fits best?en_GB
dc.typeArticleen
dc.contributor.departmentDepartment of Clinical Medicine, Trinity Centre for Health Sciences, Adelaide and Meath Hospital, Dublin, Ireland. leecs@tcd.ieen_GB
dc.identifier.journalExpert review of gastroenterology & hepatologyen_GB
dc.description.provinceLeinsteren

Related articles on PubMed

All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.